SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001685071-19-000018
Filing Date
2019-06-27
Accepted
2019-06-27 08:29:26
Documents
4
Period of Report
2019-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dova8-kamendmenttomaterial.htm 8-K 32564
2 EXHIBIT 10.1 exhibit101amendmenttoco-pr.htm EX-10.1 75376
3 EXHIBIT 99.1 exhibit991dopteletitpappro.htm EX-99.1 23673
4 dopteletitpapprovalpr_image1.gif GRAPHIC 20423
  Complete submission text file 0001685071-19-000018.txt   161111
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 19923011
SIC: 2834 Pharmaceutical Preparations